Prophylaxis of Neuropathic Pain by mémantine

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Neuropathic Pain
Interventions
DRUG

Memantine EBIXA®

The aim of this study is to evaluate if memantine administered during 4 weeks beginning 2 weeks before surgery induces a decrease of painful intensity 3 months after surgery, compared to placebo group.

DRUG

Placebo : lactose

The aim of this study is to evaluate if memantine administered during 4 weeks beginning 2 weeks before surgery induces a decrease of painful intensity 3 months after surgery, compared to placebo group.

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT01536314 - Prophylaxis of Neuropathic Pain by mémantine | Biotech Hunter | Biotech Hunter